TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Centessa Pharmaceuticals Announces Pricing of $250,000,000 Public Offering of American Depositary Shares

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Kristen K. Sheppard
Centessa Pharmaceuticals Announces Pricing of $250,000,000 Public Offering of American Depositary Shares

Centessa Pharmaceuticals has priced a public offering of 11,627,907 American Depositary Shares at $21.50 per share, expecting to raise approximately $250 million to support its clinical-stage pharmaceutical development.

Insights
CNTA   neutral

The company is raising capital through a standard public offering, which indicates a typical financial strategy for funding ongoing research and development without significant positive or negative implications